The US Food and Drug Administration approved a daily pill on July 16 that can lower cholesterol levels far below what can be achieved with statins, the cheap cholesterol-reducing pills. The drug, enlicitide, whose brand name is Lipfendra, is made by pharmaceutical company Merck. Clinical trials hav»»»

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs. The drug from Merck was OK'd on Thursday for patients with artery-clogging cholesterol that persists even a»»»

The Food and Drug Administration on Thursday approved the anti-cholesterol pill Lipfendra for use in the United States. Backers say its ability to lower bad "LDL-C" cholesterol with just a pill is a breakthrough in the field. Photo courtesy of Merck & Co. July 16 (UPI) -- Heralding what some are ca»»»

A new pill called Enlicitide from Merck offers hope for cholesterol management. This first-ever oral PCSK9 inhibitor demonstrated substantial LDL reductions in a recent trial. It works alongside statins to lower bad cholesterol. This development could be a breakthrough for patients needing more eff»»»